Scientists from Oxford University have begun their human trials, in the hope of finding a vaccine for the coronavirus. If the trials are successful, a vaccine may become available as early as September.

The trials are led by the Oxford Vaccine Group and the Jenner Institute and began last week. The development of the vaccine began in January, using the help of other vaccines for other strands of the virus. As a result of using this technology, their work is far more advanced and successful than other laboratories, who are yet to begin their human trials.

The human trials began after the vaccine was tested on monkeys in the National Institutes of Health’s Rocky Mountain Laboratory. The vaccine was injected into six different rhesus macaque monkeys, which were then exposed to the high doses of the coronavirus, a month later, they remained in good health. Dr. Vincent Munster is involved in the research and said, “The rhesus macaque is pretty much the closest thing we have to humans,” when interviewed by the New York Times.

“The vaccine is made from a weakened version of a common cold virus, or adenovirus, from chimpanzees and has been “genetically changed so that it is impossible for it to grow in humans,” reported the University Hospital Southampton. 

Like Oxford University, a pharmaceutical company, Pfizer, and a company from Germany are working together to produce a vaccine by fall. According to both companies, they will begin to experiment on humans in the U.S. later this week. The study began on April 23, 2020, in Germany with volunteers from the age of 18-55. Nevertheless, the results of the study have yet to be published. The company also stated, “In addition, the safety and immunogenicity of the vaccine will be investigated,”

Officials have reported that several vaccine programs are working on developing a vaccine against the coronavirus and are in the clinical trial phase, they also stated that more than 80 are currently in the preliminary phase. 

Currently, none of the vaccines or treatments presented by these institutions have been approved, and will not be approved for several months after more testing is conducted. Considering the information, are Americans willing to receive the vaccine?